NCT03681574View on ClinicalTrials.gov

Gabapentin as Preanesthetic Medication to Fast Procedures in Pediatric´s Oncology

PHASE4CompletedINTERVENTIONAL
Enrollment

135

Participants

Timeline

Start Date

July 1, 2017

Primary Completion Date

July 1, 2018

Study Completion Date

August 1, 2018

Conditions
Pain, PostoperativeAgitation States as Acute Reaction to Exceptional StressAnesthesiaVomiting
Interventions
DRUG

Placebo Group

Patients will be submitted to either myelogram or lumbar puncture procedure. Before that they will receive placebo concentrate.

DRUG

GABA 15mg/kg Group

Patients will be submitted to either myelogram or lumbar puncture procedure. Before that they will receive gabapentin at 15mg/kg.

DRUG

GABA 30mg/kg Group

Patients will be submitted to either myelogram or lumbar puncture procedure. Before that they will receive gabapentin at 30mg/kg.

Trial Locations (1)

60410794

Hospital Infantil Albert Sabin, Fortaleza

All Listed Sponsors
lead

Hospital Infantil Albert Sabin

OTHER

NCT03681574 - Gabapentin as Preanesthetic Medication to Fast Procedures in Pediatric´s Oncology | Biotech Hunter | Biotech Hunter